コンパニオンアニマルヘルスの市場規模、シェア、成長分析、製品タイプ別、動物タイプ別、流通チャネル別、地域別 - 産業予測、2024年～2031年

コンパニオンアニマルヘルスの世界市場規模は、2022年に191億米ドルと評価され、2023年の204億米ドルから2031年には345億3,000万米ドルに成長し、予測期間中（2024-2031年）のCAGRは6.80％で成長する見通しです。

動物用医薬品市場は、動物の健康増進を目的とした官民両部門の共同イニシアチブに牽引され、大きな成長を遂げるものと思われます。特に、米国獣医師会（AVMA）、国連食糧農業機関（FAO）、世界動物保健機関（OIE）などの組織が参加するワンヘルス・イニシアチブは、さまざまなガバナンス・レベルでの効果的な政策実施を通じて人獣共通感染症を管理し、公衆衛生を守ろうとしています。ペットの飼い方が進化するにつれて、ペットの人間化が進み、ペットの健康と安全に対する関心が高まり、飼い主がペットの健康に投資するようになった。人間と動物との間の感情的な結びつきが強まるにつれ、消費者はペットの世話に多くの予算を割くようになった。この動向は、米国におけるペット健康保険への需要の高まりによってさらに増幅され、ペットの健康を守るための積極的なアプローチを反映しています。このような新興国市場力学により、動物医療市場の利害関係者は、包括的なペットケアと健康管理への注目の高まりを利用するのに有利な立場にあり、消費者の意識と需要が高まる中、動物医療への投資が引き続き牽引役となり、有利な機会を提示しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• ケーススタディ

コンパニオンアニマルヘルスの市場規模：製品タイプ別& CAGR（2024-2031）

• 市場概要
• ワクチン
• 医薬品
  • OTC
  • 処方箋
• 飼料添加物
• 診断
• その他

コンパニオンアニマルヘルスの市場規模：動物タイプ別& CAGR（2024-2031）

• 市場概要
• 犬
• 猫
• 馬
• その他のペット

コンパニオンアニマルヘルスの市場規模：流通チャネル別& CAGR（2024-2031）

• 市場概要
• 小売り
• eコマース
• 病院薬局

コンパニオンアニマルヘルスの市場規模：エンドユーザー別& CAGR（2024-2031）

• 市場概要
• 動物病院・クリニック
• 診断研究所
• 調査機関および大学
• 在宅ケアの設定

コンパニオンアニマルヘルスの市場規模：地域別& CAGR（2024-2031）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東およびアフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Boehringer Ingelheim International GmbH
• Zoetis Inc.
• Merck & Co., Inc.
• Elanco Animal Health Incorporated
• IDEXX Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Biomerieux SA
• Virbac
• Norbrook Laboratories Limited
• Neogen Corporation
• Fujifilm Holdings Corporation
• Indical Bioscience GmbH
• Shenzhen Mindray Animal Medical Technology Co., Ltd.
• Bionote
• Skyla Corporation
• Euroimmun Medizinische Labordiagnostika Ag
• Urit Medical Electronic Co., Ltd
• Nova Biomedical
• Fassisi Gmbh
• Alvedia
• Agrolabo S.P.A

結論と推奨事項

Global Companion Animal Health Market size was valued at USD 19.10 billion in 2022 and is poised to grow from USD 20.40 billion in 2023 to USD 34.53 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).

The market for animal health is set to experience significant growth, driven by collaborative initiatives from both public and private sectors aimed at enhancing animal health. Notably, the One Health Initiative, involving organizations such as the American Veterinary Medical Association (AVMA), Food and Agriculture Organization (FAO), and World Organization for Animal Health (OIE), seeks to protect public health by managing zoonotic diseases through effective policy implementation at various governance levels. As pet ownership evolves, the humanization of pets has sparked heightened concerns regarding their health and safety, influencing owners to invest more in their well-being. The growing emotional bond between humans and animals has catalyzed consumer willingness to allocate a larger budget for pet care. This trend is further amplified by the rising demand for pet health insurance in the United States, reflecting a proactive approach towards safeguarding pet health. With these developing dynamics, stakeholders in the animal health market are well-positioned to capitalize on the increasing focus on comprehensive pet care and health management, presenting lucrative opportunities as investments in animal health continue to gain traction amid rising consumer awareness and demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Health market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Health Market Segmental Analysis

Due to the increasing pet population, rising investment in the healthcare sector, and the presence of top healthcare service providers, North America held the greatest revenue share of more than 40% in 2021 and is anticipated to hold the lead during the forecast period. Additionally, the rise of the animal healthcare market in this region is projected to be fueled by technology advancements, increase in pet ownership, and increase in the frequency of zoonotic diseases.

Driver of the Global Companion Animal Health Market

The Companion Animal Health market is significantly influenced by several key factors. A notable driver is the rising adoption of artificial intelligence, which enhances diagnostic capabilities and drives industry growth. In the United States, the increasing number of companion animals is expected to fuel market expansion further. Additionally, the growing availability of insurance policies to cover accidents is projected to contribute positively to the sector. The rise in cancer cases among dogs also plays a crucial role in driving demand. Other contributing factors include the expansion of veterinary practices, urbanization, and heightened consumer demand for animal healthcare products. Investment in pharmaceutical development to enhance drug and vaccine quality, combined with societal shifts towards nuclear families and increased government support for veterinary care, are vital elements propelling the market forward.

Restraints in the Global Companion Animal Health Market

The Global Companion Animal Health market is currently facing several significant restraints. The growing awareness of zoonotic diseases has resulted in a surge of abandoned pets as people fear transmitting viruses from animals to humans. Additionally, the COVID-19 pandemic disrupted supply chains, leading to shortages of essential animal health products such as vaccines and feed. Furthermore, stringent government regulations restricting the importation of raw materials from China are expected to hinder market growth. Moreover, the lack of market standardization and the high costs associated with products and diagnostics pose additional challenges, ultimately limiting the expansion of the companion animal health sector.

Market Trends of the Global Companion Animal Health Market

The Global Companion Animal Health market is witnessing a significant trend towards personalization and premium services, driven by the evolving needs of pet owners. Grooming centers, daycare facilities, and pet-friendly establishments are increasingly offering bespoke services tailored to the specific requirements of pets, including skin and fur treatments and customized accessories. The rise of start-ups in regions like India is further enhancing this trend by providing innovative online services that cater to pet ownership, veterinary advice, and even travel planning for pet owners. Additionally, the emergence of health monitoring and training apps is reinforcing the focus on pet wellness, positioning personalized care as a key driver in the companion animal health sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Companion Animal Health Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Vaccines
• Pharmaceuticals
  • OTC
  • Prescription
• Feed Additives
• Diagnostics
• Others

Global Companion Animal Health Market Size by Animal Type & CAGR (2024-2031)

• Market Overview
• Dog
• Cat
• Horse
• Other Companion Animals

Global Companion Animal Health Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Retail
• E-commerce
• Hospital pharmacies

Global Companion Animal Health Market Size by End User & CAGR (2024-2031)

• Market Overview
• Veterinary Hospitals & Clinics
• Diagnostics Laboratories
• Research Institutes & Universities
• Home-care Settings

Global Companion Animal Health Market Size & CAGR (2024-2031)

• North America, (Product Type, Animal Type, Distribution Channel, End User)
  • US
  • Canada
• Europe, (Product Type, Animal Type, Distribution Channel, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product Type, Animal Type, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product Type, Animal Type, Distribution Channel, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product Type, Animal Type, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indical Bioscience GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skyla Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Euroimmun Medizinische Labordiagnostika Ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Urit Medical Electronic Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrolabo S.P.A
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation